Flonoltinib 75mg: Clinical Trials

3 trials of Flonoltinib 75mg, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 1 completed. 1 Phase 1, 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 21Recruiting 1
Phase 31Recruiting 1

Follow Flonoltinib 75mg: new trials by email Literature Review of Flonoltinib 75mg trials Research Report on Flonoltinib 75mg

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Mass Balance Study of [14C] Flonoltinib Maleate
Flonoltinib 75mg - MB
Phase 1CompletedChengdu Zenitar Biomedical Technology Co., Ltd62026-07-062026-08-13
A Clinical Trial of Flonoltinib Maleate for Intermediate or High-Risk Myelofibrosis
Flonoltinib 75mg, Ruxolitinib Phosphate - MF
Phase 3RecruitingChengdu Zenitar Biomedical Technology Co., Ltd1052026-02-132026-08-13
Phase IIa Study of Flonoltinib Maleate Tablets in the Treatment of Patients With Polycythemia Vera
Flonoltinib 75mg, Flonoltinib 100mg, Flonoltinib 125mg - Polycythemia Vera (PV)
Phase 2RecruitingChengdu Zenitar Biomedical Technology Co., Ltd602025-09-232026-08-14

Conditions studied

Polycythemia Vera (1)

Sponsors

Chengdu Zenitar Biomedical Technology Co., Ltd (3)

Countries

China (3)

Top investigators

Lei Zhang, Doctor (1)  ·  Miao Jia, Doctor (1)  ·  Niu Ting, Doctor (1)  ·  Ting Niu, Doctor (1)  ·  Wei Yang, Doctor (1)  ·  Xiao Zhijian, Doctor (1)